organophosphonates has been researched along with Critical Illness in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gattringer, KB; Jäger, W; Kraff, S; Thalhammer, F; Vossen, MG | 1 |
Anglada Martínez, H; Carcelero San Martín, E; Castro Rebollo, P; Soy Muner, D | 1 |
Chen, WL; Wei, SJ; Wu, MS; Xiao, L; Yang, Z; Zhao, LZ | 1 |
3 other study(ies) available for organophosphonates and Critical Illness
Article | Year |
---|---|
Single-dose pharmacokinetics of cidofovir in continuous venovenous hemofiltration.
Topics: Antiviral Agents; Cidofovir; Critical Illness; Cytosine; Hemofiltration; Humans; Male; Middle Aged; Organophosphonates; Probenecid | 2014 |
[Cidofovir dosage in a critically ill patient undergoing continuous veno-venous hemodiafiltration].
Topics: Adenovirus Infections, Human; Antiviral Agents; Cidofovir; Critical Illness; Cytosine; Female; Hemofiltration; Humans; Organophosphonates; Young Adult | 2014 |
[Non-standard discontinuation of adefovir dipivoxil causing acute exacerbation of hepatitis].
Topics: Adenine; Adult; Antiviral Agents; Biomarkers; Critical Illness; Cytokines; DNA, Viral; Follow-Up Studies; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lymphocyte Count; Male; Organophosphonates; Recurrence; T-Lymphocytes; Time Factors; Treatment Outcome | 2009 |